Bluelinea Société Anonyme (EPA:ALBLU)
France
· Delayed Price · Currency is EUR 0.484
+0.002 (0.41%)
Mar 9, 2026, 9:00 AM CET
Bluelinea Société Anonyme Revenue
Bluelinea Société Anonyme had revenue of 5.37M EUR in the half year ending June 30, 2025, a decrease of -1.58%. This brings the company's revenue in the last twelve months to 11.68M, up 8.71% year-over-year. In the year 2024, Bluelinea Société Anonyme had annual revenue of 10.86M, down -0.85%.
Revenue (ttm)
11.68M
Revenue Growth
+8.71%
P/S Ratio
0.76
Revenue / Employee
131.26K
Employees
89
Market Cap
8.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.86M | -92.82K | -0.85% |
| Dec 31, 2023 | 10.96M | -485.42K | -4.24% |
| Dec 31, 2022 | 11.44M | 3.35M | 41.33% |
| Dec 31, 2021 | 8.10M | 848.69K | 11.71% |
| Dec 31, 2020 | 7.25M | 242.52K | 3.46% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SpineGuard | 4.32M |
| Carmat | 7.34M |
| Biosynex | 97.95M |
| Mauna Kea Technologies | 8.18M |
| Ikonisys | 1.47M |
| Theraclion | 1.87M |
| Novacyt | 22.69M |
| Implanet | 11.10M |